Zevra Therapeutics, Inc. (ZVRA) Dividend History

Zevra Therapeutics, Inc. (ZVRA) is a biopharmaceutical company focused on developing therapies for neurological and psychiatric disorders. The company aims to create innovative treatments by leveraging its expertise in neuropharmacology, targeting unmet medical needs in areas such as movement disorders and pain management.

1180 Celebration Boulevard, Suite 103, Celebration, FL, 34747
Phone: (321) 939-3416
Website: https://www.zevra.com

Dividend History

Zevra Therapeutics, Inc. currently does not pay dividends

Company News

Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million

Zevra Therapeutics has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher for $150 million, strengthening its balance sheet and supporting its strategic priorities.

Benzinga
Zevra Therapeutics Announces Organizational Changes

Zevra Therapeutics is consolidating its development and scientific functions under the Chief Medical Officer, resulting in the departure of the Chief Development Officer and Chief Scientific Officer. The company is also discontinuing its in-house drug discovery activities and closing its laboratory facilities to focus on late-stage clinical development and commercial opportunities.

GlobeNewswire Inc.
Zevra Therapeutics (ZVRA) Reports Q1 Loss, Lags Revenue Estimates

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of 18.37% and 2.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Page data last updated 08/19/2025 10:47:43 UTC